Abstract
Adoptive transfer of CD4+CD25+ regulatory T cells has been shown to have therapeutic effects in experimental graft-vs-host disease (GVHD) models. Chemokines play an important role in the recruitment of alloreactive donor T cells into target organs during GVHD. In this study, we investigated the effectiveness of targeted delivery of CD4+CD25+ regulatory T cells via a transfected chemokine receptor on reduction of organ damage during acute GVHD. High levels of expression of Th1-associated chemokines (CXCL9, CXCL10 and CXCL11) and their receptor CXCR3 were observed in the liver, lung and intestine of GVHD-induced recipient mice. Recipient mice that had undergone transfer of CD4+CD25+Foxp3+ CXCR3-transfected T cells (CXCR3-Treg cells) showed significant amelioration of GVHD changes in the liver, lung and intestine in comparison with recipient mice that had received CD4+CD25+Foxp3+ T cells (Treg cells) or naturally occurring CD4+CD25+ regulatory T cells. This was due to more pronounced migration of CXCR3-Treg cells and their localization for a longer time in Th1-associated chemokine-expressing organs, resulting in stronger suppressive activity. We succeeded in preparing chemokine receptor-expressing Treg cells and demonstrated their ability to ameliorate disease progression upon accumulation in target organs. This method may provide a new therapeutic approach for organ damage in acute GVHD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bolanos-Meade J . Update on the management of acute graft-versus-host disease. Curr Opin Oncol 2006; 18: 120–125.
Ferrara JL, Reddy P . Pathophysiology of graft-versus-host disease. Semin Hematol 2006; 43: 3–10.
Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS . Leukocyte migration and graft-versus-host disease. Blood 2005; 105: 4191–4199.
Murai M, Yoneyama H, Harada A, Yi Z, Vestergaard C, Guo B et al. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease. J Clin Invest 1999; 104: 49–57.
Serody JS, Burkett SE, Panoskaltsis-Mortari A, Ng-Cashin J, McMahon E, Matsushima GK et al. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 2000; 96: 2973–2980.
New JY, Li B, Koh WP, Ng HK, Tan SY, Yap EH et al. T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease. Bone Marrow Transplant 2002; 29: 979–986.
Panoskaltsis-Mortari A, Hermanson JR, Taras E, Wangensteen OD, Serody JS, Blazar BR . Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1 alpha (CCL3) after allogeneic BMT in mice. Blood 2003; 101: 3714–3721.
Ichiba T, Teshima T, Kuick R, Misek DE, Liu C, Takada Y et al. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 2003; 102: 763–771.
Sasaki M, Hasegawa H, Kohno M, Inoue A, Ito MR, Fujita S . Antagonist of secondary lymphoid-tissue chemokine (CCR ligand 21) prevents the development of chronic graft-versus-host disease in mice. J Immunol 2003; 170: 588–596.
Rao AR, Quinones MP, Garavito E, Kalkonde Y, Jimenez F, Gibbons C et al. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease. J Immunol 2003; 171: 4875–4885.
Duffner U, Lu B, Hildebrandt GC, Teshima T, Williams DL, Reddy P et al. Role of CXCR3-induced donor T-cell migration in acute GVHD. Exp Hematol 2003; 31: 897–902.
Sugerman PB, Faber SB, Willis LM, Petrovic A, Murphy GF, Pappo J et al. Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol 2004; 164: 2189–2202.
Welniak LA, Wang Z, Sun K, Kuziel W, Anver MR, Blazar BR et al. An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease. Exp Hematol 2004; 32: 318–324.
Varona R, Gadenas V, Gomez L, Martinez AC, Marquez G . CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses. Blood 2005; 106: 18–26.
Jaksch M, Remberger M, Mattsson J . Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 280–287.
Wysocki CA, Burkett SB, Panoskaltsis-Mortari A, Kirby SL, Luster AD, McKinnon K et al. Differential roles for CCR5 expression on donor T cells during graft-versus-host disease based on pretransplant conditioning. J Immunol 2004; 173: 845–854.
Mapara MY, Leng C, Kim YM, Bronson R, Lokshin A, Luster A et al. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR. Biol Blood Marrow Transplant 2006; 12: 623–634.
Sakaguchi S . Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531–562.
Masteller EL, Tang Q, Bluestone JA . Antigen-specific regulatory T cells–ex vivo expansion and therapeutic potential. Semin Immunol 2006; 18: 103–110.
Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057–1061.
Fontenot JD, Gavin MA, Rudensky AY . Foxp3 programs the development and function of CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 330–336.
Khattri R, Cox T, Yasayko SA, Ramsdell F . An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 337–342.
Thornton AM, Shevach EM . CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287–296.
Lim HW, Hillsamer P, Banham AH, Kim CH . Direct suppression of B cells by CD4+CD25+ regulatory T cells. J Immunol 2005; 175: 4180–4183.
Azuma T, Takahashi T, Kunisato A, Kitamura T, Hirai H . Human CD4+CD25+ regulatory T cells suppress NKT cell functions. Cancer Res 2003; 63: 4516–4520.
Cederbom L, Hall H, Ivars F . CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000; 30: 1538–1543.
Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV . Human CD4+CD25+ regulatory T cells restrain the maturation and antigen-presenting function of dendritic cells. J Immunol 2004; 172: 4676–4680.
Taylor PA, Lees CJ, Blazar BR . The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493–3499.
Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S . Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389–399.
Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL . CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196: 401–406.
Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003; 112: 1688–1696.
Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S et al. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003; 9: 1144–1150.
Joffre O, Gorsse N, Romagnoli P, Hudrisier D, van Meerwijk JP . Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood 2004; 103: 4216–4221.
Taylor PA, Panoskaltsis-Mortari A, Swedin JM, Lucas PJ, Gress RE, Levine BL et al. L-selectinhi but not the L-selectinlo CD4+CD25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004; 104: 3804–3812.
Ermann J, Hoffmann P, Edinger M, Dutt S, Blankenberg FG, Higgins JP et al. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD. Blood 2005; 105: 2220–2226.
Wysocki CA, Jiang Q, Panoskaltsis-Mortari A, Taylor PA, McKinnon KP, Su L et al. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 2005; 106: 3300–3307.
Hanash AM, Levy RB . Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 2005; 105: 1828–1836.
Yamazaki S, Patel M, Harper A, Bonito A, Fukuyama H, Pack M et al. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci USA 2006; 103: 2758–2763.
Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007; 445: 931–935.
Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY . Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007; 445: 936–940.
Wan YY, Flavell RA . Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007; 445: 766–770.
Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007; 445: 771–775.
Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG . B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001; 2: 1126–1132.
Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001; 194: 847–853.
Colantonio L, Iellem A, Sinigaglia F, D'Ambrosio D . Skin-homing CLA+ T cells and regulatory CD25+ T cells represent major subsets of human peripheral blood memory T cells migrating in response to CCL1/I-309. Eur J Immunol 2002; 32: 3506–3514.
Szanya V, Ermann J, Taylor C, Holness C, Fathman CG . The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses 1-selectin and high levels of CCR7. J Immunol 2002; 169: 2461–2465.
Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A . Homeostasis and energy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002; 3: 33–41.
Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL . Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204–3213.
Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Crawford JM et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 88: 3230–3239.
Cooke KR, Hill GR, Crawford JM, Bungard D, Brinson YS, Delmonte J et al. Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998; 102: 1882–1891.
Blazar BR, Taylor PA, McElmurry R, Tian L, Panoskaltsis-Mortari A, Lam S et al. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood 1998; 92: 3949–3959.
Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003; 31: 1007–1014.
Kitamura T, Onishi M, Kinoshita S, Shibuya A, Miyajima A, Nolan GP . Efficient screening of retroviral cDNA expression libraries. Proc Natl Acd Sci USA 1995; 92: 9145–9150.
Hasegawa H, Inoue A, Kohno M, Muraoka M, Miyazaki T, Terada M et al. Antagonist of interferon-inducible protein 10/CXCL10 ameliorates the progression of autoimmune sialadenitis in MRL/lpr mice. Arthritis Rheum 2006; 54: 1174–1183.
Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M et al. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice. Arthritis Rheum 2003; 48: 2555–2566.
Acknowledgements
We thank Miho Terada for an excellent technical assistance. This work was supported by a Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hasegawa, H., Inoue, A., Kohno, M. et al. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Gene Ther 15, 171–182 (2008). https://doi.org/10.1038/sj.gt.3303051
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3303051
Keywords
This article is cited by
-
Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease
Cellular & Molecular Immunology (2021)
-
Preceding Viral Infections Do Not Imprint Long-Term Changes in Regulatory T Cell Function
Scientific Reports (2020)
-
Chitinase 3-Like-1-Deficient Splenocytes Deteriorated the Pathogenesis of Acute Graft-Versus-Host Disease via Regulating Differentiation of Tfh Cells
Inflammation (2017)
-
Transcription factor IRF8 controls Th1-like regulatory T-cell function
Cellular & Molecular Immunology (2016)
-
Novel regulatory therapies for prevention of Graft-versus-host disease
BMC Medicine (2012)